Clifford Swan Investment Counsel LLC Sells 26,387 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Clifford Swan Investment Counsel LLC reduced its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBAGet Rating) by 9.8% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 242,108 shares of the pharmacy operator’s stock after selling 26,387 shares during the period. Clifford Swan Investment Counsel LLC’s holdings in Walgreens Boots Alliance were worth $7,602,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of WBA. Vontobel Holding Ltd. grew its position in Walgreens Boots Alliance by 104.6% during the first quarter. Vontobel Holding Ltd. now owns 36,922 shares of the pharmacy operator’s stock valued at $1,752,000 after acquiring an additional 18,879 shares during the last quarter. Moors & Cabot Inc. boosted its stake in shares of Walgreens Boots Alliance by 31.1% during the first quarter. Moors & Cabot Inc. now owns 20,791 shares of the pharmacy operator’s stock valued at $931,000 after purchasing an additional 4,931 shares during the period. Sequoia Financial Advisors LLC boosted its stake in shares of Walgreens Boots Alliance by 27.9% during the first quarter. Sequoia Financial Advisors LLC now owns 7,569 shares of the pharmacy operator’s stock valued at $339,000 after purchasing an additional 1,651 shares during the period. Candriam Luxembourg S.C.A. boosted its stake in shares of Walgreens Boots Alliance by 0.5% during the first quarter. Candriam Luxembourg S.C.A. now owns 63,483 shares of the pharmacy operator’s stock valued at $2,842,000 after purchasing an additional 310 shares during the period. Finally, Baird Financial Group Inc. boosted its stake in shares of Walgreens Boots Alliance by 14.2% during the first quarter. Baird Financial Group Inc. now owns 467,533 shares of the pharmacy operator’s stock valued at $20,932,000 after purchasing an additional 58,184 shares during the period. 56.71% of the stock is currently owned by institutional investors.

Insider Transactions at Walgreens Boots Alliance

In other news, EVP Kevin M. Ban sold 10,303 shares of Walgreens Boots Alliance stock in a transaction dated Friday, November 18th. The stock was sold at an average price of $40.19, for a total value of $414,077.57. Following the completion of the transaction, the executive vice president now owns 27,916 shares of the company’s stock, valued at approximately $1,121,944.04. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. In other news, EVP Kevin M. Ban sold 10,303 shares of Walgreens Boots Alliance stock in a transaction dated Friday, November 18th. The stock was sold at an average price of $40.19, for a total value of $414,077.57. Following the completion of the transaction, the executive vice president now owns 27,916 shares of the company’s stock, valued at approximately $1,121,944.04. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Nancy M. Schlichting sold 16,570 shares of the business’s stock in a transaction dated Thursday, November 17th. The stock was sold at an average price of $39.89, for a total value of $660,977.30. Following the completion of the transaction, the director now directly owns 5,515 shares of the company’s stock, valued at approximately $219,993.35. The disclosure for this sale can be found here. 17.40% of the stock is owned by insiders.

Walgreens Boots Alliance Stock Down 0.1 %

WBA traded down $0.05 during trading on Wednesday, reaching $35.85. The stock had a trading volume of 457,005 shares, compared to its average volume of 7,205,557. The stock’s 50 day moving average is $38.86 and its two-hundred day moving average is $37.22. The company has a current ratio of 0.70, a quick ratio of 0.36 and a debt-to-equity ratio of 0.32. The company has a market capitalization of $30.92 billion, a price-to-earnings ratio of -10.44, a P/E/G ratio of 1.63 and a beta of 0.75. Walgreens Boots Alliance, Inc. has a one year low of $30.39 and a one year high of $51.51.

Walgreens Boots Alliance (NASDAQ:WBAGet Rating) last posted its quarterly earnings data on Thursday, January 5th. The pharmacy operator reported $1.16 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.15 by $0.01. The business had revenue of $33.38 billion during the quarter, compared to the consensus estimate of $33.04 billion. Walgreens Boots Alliance had a positive return on equity of 13.57% and a negative net margin of 2.24%. The firm’s quarterly revenue was down 1.5% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.68 earnings per share. As a group, analysts expect that Walgreens Boots Alliance, Inc. will post 4.5 earnings per share for the current year.

Walgreens Boots Alliance Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, December 12th. Stockholders of record on Tuesday, November 15th were given a $0.48 dividend. This represents a $1.92 annualized dividend and a dividend yield of 5.36%. The ex-dividend date was Monday, November 14th. Walgreens Boots Alliance’s dividend payout ratio is presently -55.81%.

Analyst Ratings Changes

WBA has been the subject of a number of analyst reports. Evercore ISI dropped their price objective on Walgreens Boots Alliance from $41.00 to $32.00 and set an “in-line” rating for the company in a research note on Monday, October 3rd. Mizuho increased their price objective on Walgreens Boots Alliance from $36.00 to $41.00 and gave the company a “neutral” rating in a research note on Wednesday, December 14th. Deutsche Bank Aktiengesellschaft raised Walgreens Boots Alliance from a “hold” rating to a “buy” rating and raised their price target for the stock from $41.00 to $50.00 in a research note on Friday, November 11th. Credit Suisse Group dropped their price target on Walgreens Boots Alliance from $42.00 to $41.00 and set a “neutral” rating for the company in a research note on Friday, January 6th. Finally, JPMorgan Chase & Co. dropped their price target on Walgreens Boots Alliance from $42.00 to $40.00 and set a “neutral” rating for the company in a research note on Friday, January 6th. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $43.46.

Walgreens Boots Alliance Profile

(Get Rating)

Walgreens Boots Alliance, Inc operates as an integrated healthcare, pharmacy, and retailer in the United States (U.S.), the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores.

Featured Stories

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.